Operating Lease, Right-of-Use Asset of Tempest Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tempest Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Tempest Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $7,825,000, a 12% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Tempest Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,825,000 -$1,079,000 -12% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $8,104,000 -$1,055,000 -12% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $8,376,000 -$1,137,000 -12% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $8,643,000 -$1,309,000 -13% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $8,904,000 -$1,478,000 -14% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $9,159,000 -$1,645,000 -15% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $9,513,000 -$1,706,000 -15% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $9,952,000 -$1,698,000 -15% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $10,382,000 +$9,070,000 +691% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $10,804,000 +$9,251,000 +596% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $11,219,000 +$8,480,000 +310% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $11,650,000 +$8,599,000 +282% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 $1,312,000 -$2,045,000 -61% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $1,553,000 -$2,120,000 -58% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $2,739,000 -$312,000 -10% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $3,051,000 +$1,174,000 +63% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $3,357,000 +$1,480,000 +79% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $3,673,000 +$1,057,000 +40% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $3,051,000 +$185,000 +6.5% 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q4 2020 $1,877,000 -$1,454,000 -44% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $1,877,000 -$1,691,000 -47% 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $2,616,000 +$267,000 +11% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $2,866,000 +$2,069,000 +260% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $3,331,000 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q3 2019 $3,568,000 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $2,349,000 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $797,000 31 Mar 2019 10-Q 15 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.